Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

This study is currently recruiting participants.

Study NCT00295932 Information provided by National Cancer Institute (NCI)

First Received: February 23, 2006 Last Updated: June 18, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)